ArticleTrials2025
Efficacy of Diet on Quality of life in Multiple Sclerosis (EDQ-MS): a study protocol for a randomized controlled clinical trial.
Article in Trials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05007483 (Efficacy of Diet on Quality of Life in Multiple Sclerosis), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Efficacy of Diet on Quality of Life in Multiple Sclerosis
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundThe primary objective of this study is to evaluate the efficacy of two dietary interventions, time-restricted olive oil-based (TROO) ketogenic and modified Paleolithic elimination (MPE), compared to usual care control group receiving Dietary Guidelines for Americans (DGA) resources, on quality of life (QoL) among individuals with relapsing-remitting multiple sclerosis (RRMS). The secondary objectives are to evaluate the long-term effects on functional disability, fatigue, mood, motor, ocular and cognitive function, and disease activity.
methodsThe proposed study will consist of 162 study participants attending 3 in-person site visits at months 0, 3, and 24, with online surveys every 3 months. This study will use a randomized, single-blind, controlled design to investigate the short-term (6 months) and long-term (24 months) efficacy of intervention diets on QoL and related outcomes stated above. On-site study visits will include motor, ocular and cognitive function, as well as magnetic resonance analyses. Blood and saliva biospecimens will be collected and frozen for future metabolome and microbiome analyses, respectively. Participants assigned to TROO keto and MPE diets will be given diet-specific educational materials and dietary supplements. Usual care control group will be given DGA resources and monthly educational resources. Dietary assessments will be collected by the Diet History Questionnaire III (DHQ III) at months 0, 3, 12 and 24. Registered Dietitian Nutritionists (RDNs) will deliver the dietary intervention to the TROO and MPE groups, using Social Cognitive Theory (SCT), Self-Determination Theory, and Motivational Interviewing (MI) techniques to facilitate effective behavior change. DISCUSSION: There is an unmet need for rigorous randomized controlled trials to assess the efficacy of dietary interventions on MS-related symptoms and disease activity. The findings from this study will provide necessary information regarding the role of specific dietary interventions in MS care.
trial registrationClinicalTrials.gov, NCT05007483. Registered on August 16, 2021. https://clinicaltrials.gov/study/NCT05007483 .
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.